oral ATP-synthase inhibitor

Ph. I candidate for pulmonary tuberculosis

toxicol. risk mitigation from prev. disclosed inhibitor

Bioorg. Med. Chem. Lett.

WuXi AppTec, Shanghai, CN

Sudapyridine (WX-081) Chemical Structure, oral ATP-synthase inhibitor - WuXi AppTec, Shanghai, CN

Context. Sudapyridine (WuXi AppTec) is an oral mycobacterial ATP synthase inhibitor being developed for tuberculosis (TB). Despite the significant success achieved with the discovery of antibiotic drugs in the…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: